CD274 and lung carcinoma: Recently, pan-cancer analyses leveraging The Cancer Genome Atlas (TCGA) revealed that global DNA hypomethylation is associated with immune evasion signatures and can influence the effectiveness of anti-PD-1/PD-L1 immunotherapy in lung cancer, even in tumors with high mutational burden [102,103].